Doctors in the United States have performed the first advanced lung transplant on a PATIENT with A COVID-19 patient after a patient with new coronary pneumonia suffered severe lung damage and had to rely on a ventilator to support his life,media reported. The high-risk surgery was performed at Northwest Memorial Hospital, and experts concluded that without two new lungs, patients would not have a chance of survival.
Although the uncertainty surrounding COVID-19 remains, some aspects of the virus and its effects on the human body are already clear. The new coronavirus can have a significant impact on the lungs, especially in the late stages of infection. This can lead to pneumonia, acute respiratory distress syndrome and sepsis, causing lasting damage.
The transplant was performed six weeks after the special COVID patient, a Hispanic woman in her 20s, entered the intensive care unit. This involves the work of her damaged heart and lungs, supported by a ventilator and an in vitro membrane oxygenation (ECMO) machine. Even with this support, the hospital said, “by early June, the patient had irreversible damage to his lungs.”
Part of the challenge is that, although transplants are clearly necessary if the woman is to survive. “For many days, she was probably the most sick person in the entire hospital in the COVID ICU,” said Beth Malsin, a lung and intensive care specialist at Northwestern Memorial Hospital. “There are so many times, day and night, that our team must respond quickly to help her oxygenate and support her other organs to make sure they are healthy enough to support the transplant if and when the opportunity comes.” “
Dr. Ankit Bharat, director of thoracic surgery, described the surgery as “quite technically challenging.” According to Northwestern Medicine, more than 85 to 90 percent of lung transplant patients survive for a year. Nevertheless, there are still many problems. Although the full medical records of the PATIENT have not been released, the hospital described her as “a healthy woman in her 20s.” “We don’t know much about COVID-19,” admits Dr. Rade Tomic, a pulmonary physician and medical director of the hospital’s lung transplant program. “For example, why are some cases worse off than others?” “